ID
26253
Description
Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Investigational product
Mots-clés
Versions (4)
- 21/09/2017 21/09/2017 -
- 13/10/2017 13/10/2017 -
- 23/10/2017 23/10/2017 -
- 22/12/2017 22/12/2017 -
Détendeur de droits
GlaxoSmithKline
Téléchargé le
13 octobre 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Investigational product GSK study Chronic Coronary Heart Disease NCT00799903
Investigational product GSK study Chronic Coronary Heart Disease NCT00799903
Description
Investigational product discontinuation
Description
investigational product stopped permanently
Type de données
text
Description
Select "Protocol deviation" if none of the other primary reasons are appropriate. Select "Decision by subject or proxy" if none of the other primary reasons are appropriate. In case of "Adverse Event", record details on the Non-Serious Adverse Events or Serious Adverse Events forms as appropriate. Check all that apply. If none, select "No Subreasons".
Type de données
text
Description
Record details on the Non-Serious Adverse Events or Serious Adverse Events forms as appropriate. Check all that apply. If none, select "No Subreasons":
Type de données
boolean
Description
Adverse event MACE
Type de données
boolean
Description
Select this reason if none of the other primary reasons are appropriate.
Type de données
text
Description
Select this reason if none of the other primary reasons are appropriate.
Type de données
text
Description
Sponsor terminated study treatment specification
Type de données
text
Description
Investigator site closed specification
Type de données
text
Description
Post-IP Follow-up status
Description
Select type [1] if telephone follow-up was accepted by subject. Please complete TELE visit form for each contact. In case of type [2], please complete THIRD PARTY visit form for each contact. In case of type [3], please complete CONC form within EOS visit.
Type de données
integer
Description
Fill in in case "Post-IP Phone Follow-up With Subject" or "Post-IP Follow-up through designated third party" has been selected.
Type de données
text
Description
Contact frequency other
Type de données
text
Description
Authorization status
Type de données
text